Skip to Main Content

Author Details

Igor Zhukov
Institute of Biochemistry and Biophysics, Polish Academy of Sciences
1999
62
18
Andrej Sali (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37517559Why does the herpes simplex 1 virus-encoded UL49.5 protein fail to inhibit the TAP-dependent antigen presentation?Biochim Biophys Acta Biomembr2023
35143147The engineered peptide construct NCAM1-Aβ inhibits fibrillization of the human prion protein (PrP).Acta Biochim Pol2022
33427369Investigation of the Effects of Primary Structure Modifications within the RRE Motif on the Conformation of Synthetic Bovine Herpesvirus 1-Encoded UL49.5 Protein Fragments.Chem Biodivers2021
33546456Diketopiperazine-Based, Flexible Tadalafil Analogues: Synthesis, Crystal Structures and Biological Activity Profile.Molecules2021
34737343Zn(II) binding causes interdomain changes in the structure and flexibility of the human prion protein.Sci Rep2021
34781677Intermediate Cu(II)-Thiolate Species in the Reduction of Cu(II)GHK by Glutathione: A Handy Chelate for Biological Cu(II) Reduction.Inorg Chem2021
34677523The Natural Oligoribonucleotides Functionalized by D-Mannitol Affected Interactions of Hemagglutinin with Glycan Receptor Indicating Anti-Influenza Activity.Membranes (Basel)2021
31330077NMR and crystallographic structural studies of the extremely stable monomeric variant of human cystatin C with single amino acid substitution.FEBS J2020
31963646Disulfide-Linked Peptides for Blocking BTLA/HVEM Binding.Int J Mol Sci2020
33374409The Influence of the Mixed DPC:SDS Micelle on the Structure and Oligomerization Process of the Human Cystatin C.Membranes (Basel)2020
33374166DMPC Phospholipid Bilayer as a Potential Interface for Human Cystatin C Oligomerization: Analysis of Protein-Liposome Interactions Using NMR Spectroscopy.Membranes (Basel)2020
33276669The Palladium(II) Complex of A<i>β</i><sub>4-16</sub> as Suitable Model for Structural Studies of Biorelevant Copper(II) Complexes of N-Truncated Beta-Amyloids.Int J Mol Sci2020
32722282Structural Analysis of the SANT/Myb Domain of FLASH and YARP Proteins and Their Complex with the C-Terminal Fragment of NPAT by NMR Spectroscopy and Computer Simulations.Int J Mol Sci2020
30756103Electronic properties of a PrP<sup>C</sup>-Cu(ii) complex as a marker of 5-fold Cu(ii) coordination.Metallomics2019
35519468PrP (58-93) peptide from unstructured N-terminal domain of human prion protein forms amyloid-like fibrillar structures in the presence of Zn<sup>2+</sup> ions.RSC Adv2019
31358826Rational drug-design approach supported with thermodynamic studies - a peptide leader for the efficient bi-substrate inhibitor of protein kinase CK2.Sci Rep2019
31454948Structural Analysis and Dynamic Processes of the Transmembrane Segment Inside Different Micellar Environments-Implications for the TM4 Fragment of the Bilitranslocase Protein.Int J Mol Sci2019
30772281Structure determination of UL49.5 transmembrane protein from bovine herpesvirus 1 by NMR spectroscopy and molecular dynamics.Biochim Biophys Acta Biomembr2019
35559094Clear distinction between CAC and CMC revealed by high-resolution NMR diffusometry for a series of bis-imidazolium gemini surfactants in aqueous solutions.RSC Adv2018
28522546The RxLR Motif of the Host Targeting Effector AVR3a of <i>Phytophthora infestans</i> Is Cleaved before Secretion.Plant Cell2017
27216451Revised stability constant, spectroscopic properties and binding mode of Zn(II) to FluoZin-3, the most common zinc probe in life sciences.J Inorg Biochem2016
26613873MR Imaging Biomarkers in Oncology Clinical Trials.Magn Reson Imaging Clin N Am2016
26291722Structural Model of the Bilitranslocase Transmembrane Domain Supported by NMR and FRET Data.PLoS One2015
24211821NMR structural studies of the first catalytic half-domain of ubiquitin activating enzyme.J Struct Biol2014
25261014The TFE-induced transient native-like structure of the intrinsically disordered Ͽ⿿⁷⁰ domain of Escherichia coli RNA polymerase.Eur Biophys J2014
25233114Atomic resolution structure of a protein prepared by non-enzymatic His-tag removal. Crystallographic and NMR study of GmSPI-2 inhibitor.PLoS One2014
22392337(1)H, (13)C, and (15)N chemical shifts assignments for human endothelial monocyte-activating polypeptide EMAP II.Biomol NMR Assign2013
23774522Structural elucidation of transmembrane transporter protein bilitranslocase: conformational analysis of the second transmembrane region TM2 by molecular dynamics and NMR spectroscopy.Biochim Biophys Acta2013
22676969Structural basis for the protective effect of the human prion protein carrying the dominant-negative E219K polymorphism.Biochem J2012
22989881Post-translational S-nitrosylation is an endogenous factor fine tuning the properties of human S100A1 protein.J Biol Chem2012
22745694Structural analysis of a peptide fragment of transmembrane transporter protein bilitranslocase.PLoS One2012
21138844Structure and dynamics of the first archaeal parvulin reveal a new functionally important loop in parvulin-type prolyl isomerases.J Biol Chem2011
21839748Toward the molecular basis of inherited prion diseases: NMR structure of the human prion protein with V210I mutation.J Mol Biol2011
21296671Solution NMR structure and dynamics of human apo-S100A1 protein.J Struct Biol2011
19847776Backbone dynamics of TFE-induced native-like fold of region 4 of Escherichia coli RNA polymerase sigma70 subunit.Proteins2010
20661422NMR structure of the human prion protein with the pathological Q212P mutation reveals unique structural features.PLoS One2010
20147370A contribution to identification of novel regulators of plant response to sulfur deficiency: characteristics of a tobacco gene UP9C, its protein product and the effects of UP9C silencing.Mol Plant2010
19213045The immunosuppressive activity and solution structures of ubiquitin fragments.Biopolymers2009
19662275The structural effects of the Cys-S-S-Cys bridge exchange by the His-Cu(II)-His motif studied on natural peptides--a promising tool for natural compounds-based design.Dalton Trans2009
19515425Histidine analogues of oxytocin and vasopressin as efficient ligands for Zn2+ ions--potentiometric and NMR studies.J Inorg Biochem2009
18088104Structural and motional changes induced in apo-S100A1 protein by the disulfide formation between its Cys 85 residue and beta-mercaptoethanol.Biochemistry2008
18376830Determination of spin-spin couplings from ultrahigh resolution 3D NMR spectra obtained by optimized random sampling and multidimensional Fourier transformation.J Am Chem Soc2008
18039921NS3 Peptide, a novel potent hepatitis C virus NS3 helicase inhibitor: its mechanism of action and antiviral activity in the replicon system.Antimicrob Agents Chemother2008
17822933Lineshapes and artifacts in Multidimensional Fourier Transform of arbitrary sampled NMR data sets.J Magn Reson2007
1796843915N magnetic relaxation study of backbone dynamics of the ribosome-associated cold shock response protein Yfia of Escherichia coli.Acta Biochim Pol2007
16488634Two-dimensional Fourier transform of arbitrarily sampled NMR data sets.J Magn Reson2006
17031529Random sampling of evolution time space and Fourier transform processing.J Biomol NMR2006
16738783NMR assignment of a structurally uncharacterised fragment of recombinant mouse ubiquitin-activating enzyme.J Biomol NMR2006
15772749A protein backbone psi and phi angle dependence of 2J(N(i),C alpha(i-1)): the new NMR experiment and quantum chemical calculations.J Biomol NMR2005
15827616Apoptosis induced by membrane damage in human lymphocytes; effects of arachidonic acid and its photoproducts.Acta Biochim Pol2005
  • 1 - 50 of 62

Recommended Authors

Tobias Madl
Gottfried Schatz Research Center, Medical University of Graz
Career Start Year 2005
Number of shared co-authors 1
Yang Shen
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Career Start Year 2002
Number of shared co-authors 1
Bernd Reif
Technische Universitat Munchen (TUM)
Career Start Year 1996
Number of shared co-authors 1
Daniel Nietlispach
University of Cambridge
Career Start Year 1996
Number of shared co-authors 1
Volker D??tsch
Institute for Biophysical Chemistry, Goethe-University
Career Start Year 1995
Number of shared co-authors 1
Ram??n Campos-Olivas
Spanish National Cancer Research Centre (CNIO)
Career Start Year 1995
Number of shared co-authors 1
Mark W Maciejewski
University of Connecticut School of Medicine
Career Start Year 1995
Number of shared co-authors 1
Michael A Kennedy
Miami University
Career Start Year 1993
Number of shared co-authors 0
Petr Nov??k
Institute of Microbiology of the CAS
Career Start Year 1991
Number of shared co-authors 1
Alexander P Golovanov
The University of Manchester
Career Start Year 1991
Number of shared co-authors 1
Geerten W Vuister
Leicester Institute of Structural and Chemical Biology, University of Leicester
Career Start Year 1988
Number of shared co-authors 1
Hartmut Oschkinat
Leibniz-Forschungsinstitut fur Molekulare Pharmakologie
Career Start Year 1988
Number of shared co-authors 1
Paul C Driscoll
The Francis Crick Institute
Career Start Year 1987
Number of shared co-authors 1
Michael Nilges
Institut Pasteur
Career Start Year 1986
Number of shared co-authors 2
Stephan Grzesiek
University of Basel
Career Start Year 1986
Number of shared co-authors 1
Roland Riek
ETH Zurich
Career Start Year 1986
Number of shared co-authors 1
Lewis E Kay
University of Toronto
Career Start Year 1985
Number of shared co-authors 2
Thomas A Frenkiel
The Medical Research Council Biomedical NMR Centre, The Francis Crick Institute
Career Start Year 1984
Number of shared co-authors 1
Lu-Yun Lian
Institute of Systems, The University of Liverpool
Career Start Year 1984
Number of shared co-authors 1
Toshimichi Fujiwara
Institute for Protein Research, Osaka University
Career Start Year 1983
Number of shared co-authors 1
Slobodan Macura
Mayo Clinic
Career Start Year 1983
Number of shared co-authors 0
Mike P Williamson
The University of Sheffield
Career Start Year 1982
Number of shared co-authors 1
Gaetano T Montelione
Rensselaer Polytechnic Institute
Career Start Year 1981
Number of shared co-authors 2
Angela M Gronenborn
University of Pittsburgh
Career Start Year 1980
Number of shared co-authors 1
Rolf Boelens
Utrecht University
Career Start Year 1979
Number of shared co-authors 1
Robert Kaptein
Utrecht University
Career Start Year 1978
Number of shared co-authors 1
David Cowburn
Albert Einstein College of Medicine
Career Start Year 1969
Number of shared co-authors 1
Ad Bax
National Institutes of Health
Career Start Year 1968
Number of shared co-authors 1
John L Markley
University of Wisconsin-Madison
Career Start Year 1967
Number of shared co-authors 1
Kurt W??thrich
iHuman Institute, ShanghaiTech University
Career Start Year 1964
Number of shared co-authors 2

Collaborators

Emilia Sikorska
University of Gdansk
Co-authored papers 7
Kosma Szutkowski
NanoBioMedical Centre, Adam Mickiewicz University
Co-authored papers 7
Amrita Roy Choudhury
Birla Institute of Technology and Science
Co-authored papers 4
Peter Bayer
University of Duisburg-Essen
Co-authored papers 4
Stefan Jurga
NanoBioMedical Centre, Adam Mickiewicz University
Co-authored papers 4
Marjana Novi??
National Institute of Chemistry
Co-authored papers 4
Andrej Sali (CM4AI)
University of California San Francisco
Co-authored papers 1
Lukasz Jaroszewski
University of California Riverside School of Medicine
Co-authored papers 1
Paweſ Krupa
Co-authored papers 1
Agnieszka Karczyſska
Co-authored papers 1
Sabina Passamonti
University of Trieste
Co-authored papers 1
Massimiliano Bonomi
Institut Pasteur, Universite Paris Cite, CNRS UMR 8
Co-authored papers 1
Johannes van den Boom
University of Duisburg-Essen
Co-authored papers 1
??ukasz Popenda
NanoBioMedical Centre, Adam Mickiewicz University
Co-authored papers 1
Release 1.2